News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Bayer AG Wins Schering AG For $22 Billion As Merck KGaA Quits
June 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, June 14 (Reuters) - Bayer finally won control of Schering on Wednesday for an increased price of almost $22 billion as Merck KGaA bowed out and sold its stake to the larger drugs and chemicals group.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
·
5 min read
·
Annalee Armstrong
Mergers & acquisitions
Novartis Drops up to $1.7B to Bolster Oligo Pipeline With Regulus Buy
April 30, 2025
·
2 min read
·
Tristan Manalac
Earnings
GSK Optimistic About M&A Prospects Despite Trump Tariff Threats
April 30, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Major Shareholder Opposes Acelyrin’s Merger With Alumis, Prefers Wind-Down
April 30, 2025
·
2 min read
·
Tristan Manalac
